For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and Attruby represents a significant advancement . These innovative therapies protect the transthyretin protein, preventing its damaging build-up and lessening the impact of the condition . Patients are now reporting… Read More